pharma · Acne Vulgaris · Plasmodium Falciparum Malaria · ATXI
AVENUE THERAPEUTICS
AVENUE THERAPEUTICS, INC.
Avenue Therapeutics is a pharma organization headquartered in Bay Harbor Islands, USA. It trades on NYSE under ticker ATXI. Primary therapeutic focus areas include Acne Vulgaris, Plasmodium Falciparum Malaria, Neural Inh
Bay Harbor Islands, USA HQ
10 Employees
Public company Type
ATXI · NYSE Ticker
Company details
- Status
- Public
- HQ
- Bay Harbor Islands, USA
- Employees
- 10
- Programs
- 4
- Drugs
- 8
- Patents
- 1
Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo]
Approved · small molecule · Acne Vulgaris
Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo] for Acne Vulgaris is a Approved program (small_molecule) at AVENUE THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Internal code EAMC IERB 2018-52
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AVENUE THERAPEUTICS, INC.
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Acne Vulgaris
- Status
- completed
- Trials
- 1